Jared Watkin - Feb 28, 2023 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
SENIOR VICE PRESIDENT
Signature
/s/ Jared Watkin by Jessica H. Paik, Attorney-in-Fact
Stock symbol
ABT
Transactions as of
Feb 28, 2023
Transactions value $
-$679,151
Form type
4
Date filed
3/2/2023, 06:59 PM
Previous filing
Feb 22, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Tax liability -$559K -5.6K -7.16% $99.77 72.6K Feb 28, 2023 Direct
transaction ABT Common shares without par value Sale -$121K -1.2K -1.65% $100.70 71.4K Mar 1, 2023 Direct
holding ABT Common shares without par value 652 Feb 28, 2023 Profit Sharing Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2023.

Remarks:

The sale transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1(c).